These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results
Wells Fargo Adjusts Price Target on Henry Schein to $75 From $80, Maintains Equalweight Rating
Henry Schein Price Target Cut to $86.00/Share From $90.00 by Barrington Research
Express News | Barrington Research Maintains Outperform on Henry Schein, Lowers Price Target to $86
Henry Schein Analyst Ratings
Henry Schein Positioned for Growth: Buy Rating Reaffirmed Amid Strategic Expansion and Board Expertise
Henry Schein to Participate in Upcoming Investor Conferences in May
Evercore Maintains Henry Schein(HSIC.US) With Hold Rating, Cuts Target Price to $68
William Blair Maintains Henry Schein(HSIC.US) With Hold Rating
Henry Schein's Earnings Call: Balancing Growth and Challenges
Earnings Call Summary | Henry Schein(HSIC.US) Q1 2025 Earnings Conference
Henry Schein Outlines 2025 Growth Targets Amid Strategic Restructuring and Stable Market Conditions
Research Alert: Hsic: Mixed Sales Trends In Dental, Medical, Q1 Eps Tops Estimates
Henry Schein | 10-Q: Q1 2025 Earnings Report
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and Axsome Therapeutics (AXSM)
Stocks Making the Biggest Moves Premarket: Howard Hughes, Henry Schein, Netflix and More
S&P 500 Futures Drop In Premarket Trading; AngloGold Ashanti, Henry Schein Lead
Henry Schein Q1 25 Earnings Conference Call At 8:00 AM ET